Christopher Byron Brooke

If you made any changes in Pure these will be visible here soon.

Filter

2020
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro
Drayman, N., Jones, K. A., Azizi, S-A., Froggatt, H. M., Tan, K., Ivanova Maltseva, N., Chen, S., Nicolaescu, V., Dvorkin, S., Furlong, K., Kathayat, R. S., Firpo, M. R., Mastrodomenico, V., Bruce, E. A., Schmidt, M. M., Jedrzejczak, R., Munoz-Alia, M. A., Schuster, B., Nair, V., Botten, J. W., & 8 othersBrooke, C. B., Baker, S. C., Mounce, B. C., Heaton, N. S., Dickinson, B. C., Jaochimiak, A., Randall, G. & Tay, S., Sep 1 2020, (In preparation) Cold Spring Harbor Laboratory Press, 32 p. (bioRxiv).
Research output: Working paper
Saliva-Based Molecular Testing for SARS-CoV-2 that Bypasses RNA Extraction
Ranoa, D. R. E., Holland, R. L., Alnaji, F. G., Green, K. J., Wang, L., Brooke, C. B., Burke, M., Fan, T. M. & Hergenrother, P., Jun 18 2020, (In preparation) Cold Spring Harbor Laboratory Press, 35 p. (bioRxiv).
Research output: Working paper

Research output